Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-046830
Filing Date
2021-07-15
Accepted
2021-07-15 19:29:58
Documents
1
Period of Report
2021-07-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6182
  Complete submission text file 0001209191-21-046830.txt   7613
Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVE BEDFORD MA 01730
Business Address
Ticho Barry (Reporting) CIK: 0001780088 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38938 | Film No.: 211093811